These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14680503)

  • 21. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells.
    Olsen N; Sokka T; Seehorn CL; Kraft B; Maas K; Moore J; Aune TM
    Ann Rheum Dis; 2004 Nov; 63(11):1387-92. PubMed ID: 15479887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
    Batteux F; Palmer P; Daëron M; Weill B; Lebon P
    Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic analysis identifies candidate genes and functional networks controlling the response of porcine peripheral blood mononuclear cells to mitogenic stimulation.
    Wilkinson JM; Dyck MK; Dixon WT; Foxcroft GR; Dhakal S; Harding JC
    J Anim Sci; 2012 Oct; 90(10):3337-52. PubMed ID: 23038743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA microarray technology in dermatology.
    Kunz M
    Semin Cutan Med Surg; 2008 Mar; 27(1):16-24. PubMed ID: 18486020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray.
    Han GM; Chen SL; Shen N; Ye S; Bao CD; Gu YY
    Genes Immun; 2003 Apr; 4(3):177-86. PubMed ID: 12700592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genes and goals: an approach to microarray analysis in autoimmunity.
    Oertelt S; Selmi C; Invernizzi P; Podda M; Gershwin ME
    Autoimmun Rev; 2005 Sep; 4(7):414-22. PubMed ID: 16137606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus.
    Nikpour M; Dempsey AA; Urowitz MB; Gladman DD; Barnes DA
    Ann Rheum Dis; 2008 Aug; 67(8):1069-75. PubMed ID: 18063674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of gene expression profiles of peripheral blood cells in systemic lupus erythematosus.
    Bae SC; Lee YH
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):40-49. PubMed ID: 30084812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Interferon-inducible genes lymphocyte antigen 6 complex E and tetratricopeptide repeats 1 are correlated with clinical features of patients with systemic lupus erythematosus].
    Tang JP; Gu YY; Shen N; Ye S; Qian J; Hua J; Chen XG; Chen SL; Bao CD; Wang Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1157-60. PubMed ID: 15387975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and function of IL-10R in mononuclear cells from patients with systemic lupus erythematosus.
    Valencia-Pacheco G; Layseca-Espinosa E; Niño-Moreno P; Portales-Pérez DP; Baranda L; Rosenstein Y; Abud-Mendoza C; González-Amaro R
    Scand J Rheumatol; 2006; 35(5):368-78. PubMed ID: 17062437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals.
    Wens B; De Boever P; Verbeke M; Hollanders K; Schoeters G
    Toxicology; 2013 Jan; 303():17-24. PubMed ID: 23146750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keys to unlocking the mysteries of rheumatic autoimmune disease.
    Moser KL; Gaffney P; Peterson E; Behrens T
    Minn Med; 2004 May; 87(5):46-51. PubMed ID: 15191068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus.
    Nzeusseu Toukap A; Galant C; Theate I; Maudoux AL; Lories RJ; Houssiau FA; Lauwerys BR
    Arthritis Rheum; 2007 May; 56(5):1579-88. PubMed ID: 17469140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
    Greenberg SA; Pinkus JL; Pinkus GS; Burleson T; Sanoudou D; Tawil R; Barohn RJ; Saperstein DS; Briemberg HR; Ericsson M; Park P; Amato AA
    Ann Neurol; 2005 May; 57(5):664-78. PubMed ID: 15852401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling meta-analysis reveals primarily gene coexpression concordance between systemic lupus erythematosus and rheumatoid arthritis.
    Silva GL; Junta CM; Mello SS; Garcia PS; Rassi DM; Sakamoto-Hojo ET; Donadi EA; Passos GA
    Ann N Y Acad Sci; 2007 Sep; 1110():33-46. PubMed ID: 17911418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-α stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus.
    Zahn S; Rehkämper C; Ferring-Schmitt S; Bieber T; Tüting T; Wenzel J
    Br J Dermatol; 2011 Nov; 165(5):1118-23. PubMed ID: 21711324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling of peripheral blood mononuclear cells (PBMC) from Mycobacterium bovis infected cattle after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD).
    Meade KG; Gormley E; Park SD; Fitzsimons T; Rosa GJ; Costello E; Keane J; Coussens PM; MacHugh DE
    Vet Immunol Immunopathol; 2006 Sep; 113(1-2):73-89. PubMed ID: 16784781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.
    Sthoeger ZM; Sharabi A; Molad Y; Asher I; Zinger H; Dayan M; Mozes E
    J Autoimmun; 2009 Aug; 33(1):77-82. PubMed ID: 19346102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.